Canadian Drug Access Pathway
…Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days)….
All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Filter by
Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…
Cost Drivers Report 2023
Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic. Read the full report….
Two years is too long – Understanding Canada’s Drug Access Pathway
Canadians wait two years for access to new medicines through our public drug plans. That’s a full year longer than patients in most other peer countries. Two years can feel…
Cost of A Private Drug Plan Claim
IMC contracted Reformulary Group to analyze the cost of a private plan prescription drug claim in Canada, and separately in Quebec. This report summarizes that analysis….
